MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-07-2026
Globus Medical Total Current Liabilities 2011-2026 | GMED
Annual Total Current Liabilities Globus Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 498 M | 856 M | 392 M | 159 M | 140 M | 121 M | 111 M | 96.1 M | 93.1 M | 79.9 M | 82.7 M | 89.4 M | 67.9 M | 39.5 M | 29.3 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 856 M | 29.3 M | 190 M |
Total Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
37.8 M | $ 4.4 | 2.33 % | $ 165 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B |  USA |
 |
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
45.8 M | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
25.3 M | - | - | $ 10.2 M | USA |
 |
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
10.8 M | $ 11.59 | 1.31 % | $ 328 M | USA |
 |
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | USA |
 |
IRIDEX Corporation
IRIX
|
13.2 M | $ 1.01 | - | $ 17.1 M | USA |
 |
Alphatec Holdings
ATEC
|
219 M | $ 8.06 | -2.6 % | $ 1.21 B | USA |
 |
Aziyo Biologics
AZYO
|
25.1 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
42.8 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
19.7 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | USA |
 |
LENSAR
LNSR
|
40.6 M | $ 5.95 | -2.3 % | $ 71.2 M | USA |
 |
Cardiovascular Systems
CSII
|
40 M | - | 0.15 % | $ 844 M | USA |
 |
Helius Medical Technologies
HSDT
|
3.02 M | $ 2.3 | 0.56 % | $ 50.7 M | USA |
 |
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | USA |
 |
Pulmonx Corporation
LUNG
|
20.1 M | $ 1.53 | -1.61 % | $ 62.2 M | USA |
 |
Cytosorbents Corporation
CTSO
|
9.71 M | $ 0.47 | 2.17 % | $ 29.2 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
46.2 M | $ 17.98 | -2.12 % | $ 422 M | USA |
 |
Myomo
MYO
|
8.35 M | $ 1.01 | -2.4 % | $ 42.3 M | USA |
 |
Delcath Systems
DCTH
|
11 M | $ 10.91 | -1.01 % | $ 391 M | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | USA |
 |
LivaNova PLC
LIVN
|
808 M | $ 75.34 | 2.05 % | $ 4.11 B |  Britain |
 |
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Orthofix Medical
OFIX
|
170 M | $ 9.62 | -10.51 % | $ 381 M |  Curacao |
 |
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | USA |
 |
Dynatronics Corporation
DYNT
|
8.24 M | - | 14.99 % | $ 929 K | USA |
 |
Profound Medical Corp.
PROF
|
6.08 M | $ 6.85 | 0.29 % | $ 207 M |  Canada |
 |
MiMedx Group
MDXG
|
64.3 M | $ 3.68 | 1.52 % | $ 544 M | USA |
 |
Electromed
ELMD
|
10.5 M | $ 37.89 | -0.86 % | $ 320 M | USA |
 |
Butterfly Network
BFLY
|
65.1 M | $ 4.53 | 1.23 % | $ 1.12 B | USA |
 |
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
6.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Sintx Technologies
SINT
|
3.73 M | $ 2.41 | 0.84 % | $ 6.68 M | USA |
 |
GBS
GBS
|
5.35 M | - | -0.57 % | $ 7.12 M | USA |
 |
Insulet Corporation
PODD
|
680 M | $ 154.12 | -0.48 % | $ 10.8 B | USA |
 |
CONMED Corporation
CNMD
|
315 M | $ 36.25 | -2.63 % | $ 1.13 B | USA |
 |
Inspire Medical Systems
INSP
|
96.1 M | $ 42.48 | -3.1 % | $ 1.25 B | USA |
 |
Integer Holdings Corporation
ITGR
|
232 M | $ 90.5 | 1.37 % | $ 3.14 B | USA |
 |
Invacare Corporation
IVC
|
220 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.81 B | $ 87.58 | 2.1 % | $ 51.2 B | USA |
 |
TransMedics Group
TMDX
|
89.3 M | $ 69.6 | 0.97 % | $ 2.37 B | USA |